SCHEMBL10132634

SCHEMBL10132634

COc1ccc(-c2c(OC)c(OC)cc3c(NC(=O)c4c(Br)ccc5c4OCO5)cccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.45
NPC1 O15118 7/20 0.40
MAPT P10636 7/20 0.40
RAB9A P51151 6/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
HSD17B10 Q99714 3/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 2/20 0.40
TSHR P16473 1/20 0.40
ABCB1 P08183 1/20 0.39
EDNRB P24530 1/20 0.37
EDNRA P25101 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 1/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132597 0.93 RXFP1 (0.45) RXFP1NPC1MAPTRAB9AALDH1A1
SCHEMBL10132615 0.93 RXFP1 (0.46) RXFP1NPC1MAPTRAB9AALDH1A1
SCHEMBL10132636 0.83 NPSR1 (0.42) MAPTRAB9ALMNASMN1; SMN2KDM4E
SCHEMBL10132623 0.82 ALDH1A1 (0.42) NPC1MAPTRAB9AALDH1A1HPGD
SCHEMBL10132867 0.80 MAPT (0.47) RXFP1NPC1MAPTRAB9AALDH1A1
SCHEMBL10161769 0.78 ABCB1 (0.44) RXFP1MAPTHSD17B10LMNASMN1; SMN2
SCHEMBL420470 0.78 MAPT (0.44) RXFP1NPC1MAPTRAB9AALDH1A1
SCHEMBL10163103 0.78 LMNA (0.43) RXFP1MAPTHPGDHSD17B10LMNA
SCHEMBL13283974 0.76 SMN1; SMN2 (0.45) RXFP1MAPTALDH1A1HPGDHSD17B10
SCHEMBL10132642 0.76 SMO (0.43) RXFP1ALDH1A1HSD17B10LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
WO-2010083436-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH RXFP1 762/4885NPC1 2668/4885MAPT 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.